SCYNEXIS
SCYX
#7968
Rank
โ‚ฌ0.35 B
Marketcap
4,47ย โ‚ฌ
Share price
-1.62%
Change (1 day)
489.88%
Change (1 year)

Revenue for SCYNEXIS (SCYX)

Revenue in 2026 (TTM): โ‚ฌ17.31 Million

According to SCYNEXIS's latest financial reports the company's current revenue (TTM ) is โ‚ฌ17.63 Million. In 2025 the company made a revenue of โ‚ฌ17.53 Million an increase over the revenue in the year 2024 that were of โ‚ฌ3.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SCYNEXIS from 2013 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ17.31 M-1.27%
2025 โ‚ฌ17.53 M387.16%
2024 โ‚ฌ3.59 M-97.16%
2023 โ‚ฌ0.12 B2571.1%
2022 โ‚ฌ4.74 M-59.17%
2021 โ‚ฌ11.62 M
2020 N/A-100%
2019 โ‚ฌ0.1 M-51.73%
2018 โ‚ฌ0.22 M4.88%
2017 โ‚ฌ0.21 M-12.34%
2016 โ‚ฌ0.24 M3.55%
2015 โ‚ฌ0.23 M-97.18%
2014 โ‚ฌ8.32 M-31.78%
2013 โ‚ฌ12.2 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Galmed Pharmaceuticals
GLMD
N/AN/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Catalyst Pharmaceuticals
CPRX
โ‚ฌ0.51 B 2,834.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
โ‚ฌ3.83 B 21,636.14%๐Ÿ‡บ๐Ÿ‡ธ USA
KemPharm
KMPH
โ‚ฌ9.06 M-48.59%๐Ÿ‡บ๐Ÿ‡ธ USA